Cargando…
Potential therapeutic options for COVID-19: an update on current evidence
SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19 pandemic and is a major public health concern nowadays. The rapid and global spread of this coronavirus leads to an increase in hospitalizations and thousands of deaths in many countries. To date, great efforts have been made...
Autores principales: | Niknam, Zahra, Jafari, Ameneh, Golchin, Ali, Danesh Pouya, Fahima, Nemati, Mohadeseh, Rezaei-Tavirani, Mostafa, Rasmi, Yousef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755901/ https://www.ncbi.nlm.nih.gov/pubmed/35027080 http://dx.doi.org/10.1186/s40001-021-00626-3 |
Ejemplares similares
-
Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms
por: Jafari, Ameneh, et al.
Publicado: (2022) -
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
por: Farahani, Masoumeh, et al.
Publicado: (2022) -
Osteogenic Differentiation Potential of Adipose-Derived Mesenchymal Stem Cells Cultured on Magnesium Oxide/Polycaprolactone Nanofibrous Scaffolds for Improving Bone Tissue Reconstruction
por: Niknam, Zahra, et al.
Publicado: (2022) -
Multiple Sclerosis Biomarker Discoveries by Proteomics and Metabolomics Approaches
por: Jafari, Ameneh, et al.
Publicado: (2021) -
Cancer Care Management During the COVID-19 Pandemic
por: Jafari, Ameneh, et al.
Publicado: (2020)